NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 11 - Eye 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing
11.04.01 Corticosteroids

Betamethasone eye drops 0.1%
(Drops )

Amber SPA
Formulary

Drops for eye, ear, nose

N.B. Eye Ointment discontinued early 2020

BNF BNFc SPC

Betamethasone with Neomycin
(Eye drops)

Amber SPA
Restricted Drug Restricted

Betamethasone 0.1%/Neomycin 0.5% Eye Drops

BNF BNFc SPC

Dexamethasone 0.1% eye drops

Amber SPA
Formulary
BNF BNFc SPC

Dexamethasone 0.1% eye drops preservative free

Amber SPA
Restricted Drug Restricted

For patients allergic to preservatives

6mL Multi dose bottle

 

Entry reviewed: June 2024

BNF BNFc SPC

Dexamethasone 700micrograms (Ozurdex®)
(Intravitreal implant)

RED
Restricted Drug Restricted

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

Approved for prescribing by Consultant Ophthalmologist in accordance with the following NICE TAs:

BNF BNFc SPC
NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis NICE TA824: Dexamethasone intravitreal implant for treating diabetic macular oedema

Dexamethasone with Neomycin and Polymyxin B sulphate (Maxitrol®)
(Eye drops / ointment)

Amber SPA
Formulary
BNF BNFc SPC

Fluocinolone 190microgram (Iluvien®)
(Intravitreal Implant )

RED
Restricted Drug Restricted

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

For prescribing by consultant Ophthalmologist in accordance with the following NICE TAs:

NB - NICE TA 613 is NEGATIVE - not recommended for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy.

BNF BNFc SPC
NICE TA301: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (replaced by NICE TA953) NICE TA590: Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uvetitis NICE TA613: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (replaced by NICE TA953) NICE TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema

Fluorometholone (FML®)
(Eye drops)

Amber SPA
Formulary

0.1% Eye Drops

BNF BNFc SPC

Hydrocortisone (Softacort®)
(Eye drops)

Amber SPA
Formulary

0.3% preservative-free single use eye drops

 

Entry reviewed: November 2022

BNF BNFc SPC

Loteprednol 0.5% (Lotemax®)
(Eye drops)

Amber SPA
Formulary
BNF BNFc SPC

Prednisolone
(Eye drops)

Amber SPA
Formulary

0.5% & 1% Eye Drops

BNF BNFc SPC

Prednisolone preservative free eye drops
(Sigle use (Minims))

Amber SPA
Restricted Drug Restricted

For patients who are allergic to preservatives
0.5% eye drops

BNF BNFc SPC
Non formulary items

Dexamethasone with Antibacterials (Tobradex®)

 
Non Formulary
BNF BNFc SPC

Hydrocortisone Acetate with Neomycin (Neo-Cortef®)

 
Non Formulary
BNF BNFc SPC

Prednisolone 0.5% with Neomycin 0.5% (Predsol-N®)

 
Non Formulary
DISCONTINUED
BNF BNFc SPC

Rimexolone (Vexol®)

 
Non Formulary
BNF BNFc SPC
11.04.01 Intravitreal corticosteroids
Classifications
GREEN
May be initiated in any care setting
Amber SPA
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Amber SPIS
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
SCG
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
RED
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
DNP
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
SELF
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.